Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adults.
Toledo-Romani ME, García-Carmenate M, Verdecia-Sánchez L, Pérez-Rodríguez S, Rodriguez-González M, Valenzuela-Silva C, Paredes-Moreno B, Sanchez-Ramirez B, González-Mugica R, Hernández-Garcia T, Orosa-Vázquez I, Díaz-Hernández M, Pérez-Guevara MT, Enriquez-Puertas J, Noa-Romero E, Palenzuela-Diaz A, Baro-Roman G, Mendoza-Hernández I, Muñoz Y, Gómez-Maceo Y, Santos-Vega BL, Fernandez-Castillo S, Climent-Ruiz Y, Rodríguez-Noda L, Santana-Mederos D, García-Vega Y, Chen GW, Doroud D, Biglari A, Boggiano-Ayo T, Valdés-Balbín Y, Rivera DG, García-Rivera D, Vérez-Bencomo V; SOBERANA Research Group. Toledo-Romani ME, et al. Among authors: perez guevara mt. Med. 2022 Nov 11;3(11):760-773.e5. doi: 10.1016/j.medj.2022.08.001. Epub 2022 Aug 8. Med. 2022. PMID: 35998623 Free PMC article. Clinical Trial.
Pretreatment HIV Drug-resistance Surveillance as a Tool for Monitoring and Control of the HIV/AIDS Epidemic in Cuba.
Machado-Zaldívar LY, Blanco-de Armas M, Dubed-Echevarría M, Díaz-Torres HM, López-Rizo LS, Pérez-Guevara MT, Lantero-Abreu MI, Rodríguez-Acosta M. Machado-Zaldívar LY, et al. Among authors: perez guevara mt. MEDICC Rev. 2021 Apr;23(2):64. doi: 10.37757/MR2021.V23.N2.11. Epub 2021 Apr 30. MEDICC Rev. 2021. PMID: 33974603 Free article.
Immunogenicity and safety assessment of a SARS-CoV-2 recombinant spike RBD protein vaccine (Abdala) in paediatric ages 3-18 years old: a double-blinded, multicentre, randomised, phase 1/2 clinical trial (ISMAELILLO study).
Cinza-Estévez Z, Resik-Aguirre S, Figueroa-Baile NL, Oquendo-Martínez R, Campa-Legrá I, Tejeda-Fuentes A, Rivero-Caballero M, González-García G, Chávez-Chong CO, Alonso-Valdés M, Hernández-Bernal F, Lemos-Pérez G, Campal-Espinosa A, Freyre-Corrales G, Benítez-Gordillo D, Gato-Orozco E, Pérez Bartutis GS, Mesa-Pedroso I, Bueno-Alemani N, Infante-Aguilar E, Rodríguez Reinoso JL, Melo-Suarez G, Limonta-Fernández M, Ayala-Ávila M, Muzio-González VL; ISMAELILLO Clinical Trial Group. Cinza-Estévez Z, et al. EClinicalMedicine. 2023 Aug 18;63:102160. doi: 10.1016/j.eclinm.2023.102160. eCollection 2023 Sep. EClinicalMedicine. 2023. PMID: 37649806 Free PMC article.
[Design and evaluation of DAVIH VIH-2].
Martín Alfonso D, Silva Cabrera E, Pérez Guevara MT, Díaz Herrera DF, Romero Martínez K, Díaz Torres HM, Lubián Caballero AL, Ruiz Gutiérrez N, Ortiz Losada E. Martín Alfonso D, et al. Among authors: perez guevara mt. Rev Cubana Med Trop. 2007 Sep-Dec;59(3):241-6. Rev Cubana Med Trop. 2007. PMID: 23427463 Clinical Trial. Spanish.
12 results